Cellebrite (CLBT): A Profitable Digital Forensics Play at 47x Earnings — Buy, Hold, or Pass?
Travis Hoium and Dan Caplinger break down Cellebrite (NASDAQ: CLBT), the digital forensics company whose tools help law enforcement crack into locked phones and pull data for criminal investigations. They cover the business, leadership under CEO Tom Hogan, the financials, and what to make of a steep valuation — landing on an overall score of 6.3 out of 10.
Topics covered:
• Cellebrite’s role in digital forensics and why law enforcement keeps coming back
• 18% revenue CAGR since 2019, expanding margins, and a recent shift to profitability
• CEO Tom Hogan’s track record and dealmaking experience
• A clean balance sheet and rising free cash flow funding R&D and expansion
• The bull/bear case at 47x trailing and ~30x forward earnings, plus AI competition risk
————————————————————————
This video is brought to you by The Motley Fool. Visit https://fool.com/Invest to get access to this special offer. The Motley Fool Stock Advisor returns are 984% as of 4/27/2026 and measured against the S&P 500 returns of 201% as of 4/27/2026. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary, not all Motley Fool Stock Advisor picks have performed as well.
————————————————————————
